Previous close | 28.33 |
Open | 32.35 |
Bid | 32.71 x 100 |
Ask | 32.87 x 100 |
Day's range | 30.35 - 34.75 |
52-week range | 18.45 - 36.66 |
Volume | |
Avg. volume | 788,590 |
Market cap | 1.379B |
Beta (5Y monthly) | 1.75 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SEATTLE, May 15, 2024--Trupanion (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, is poised to increase access for Trupanion members to lifesaving medications for treatment of otherwise deadly Feline Infectious Peritonitis (FIP). Trupanion has been providing coverage where the medications are already commercially available in Australia and Canada and is ready to continue fighting FIP in the United States in June.
SEATTLE, May 07, 2024--In recognition of Veterinary Appreciation Day™ and all the veterinary community does to support our beloved pets, Trupanion (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs announced its first annual Veterinary Appreciation Day Awards.
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2024. “It was a solid start to the year, with performance across our key financial metrics as expected,” said Margi Tooth, President of Trupanion. “Subscription revenue increased by 22% year-over-year. Moreover, discretionary profit from our core subscription business increased 55% while acqu